AllianThera Biopharma

About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease biology knowledge and drug experiences with partners’ technologies while leveraging unique strengths in different geographies, East or West. We are building a strong portfolio through internal R&D programs and external partnerships with an initial focus on diseases with unmet medical needs in immunology and cancer. 元启（苏州）生物制药：元启是一家新成立的生物技术公司，由一群资深的具有国际药厂研发及管理经验的科学家创建，通过团队在免疫学和肿瘤学方面的深厚的疾病知识以及药物发现专业特长与合作伙伴的技术相结合，同时充分利用全球各地区的不同优势，致力成为创新药物研发的领导者。ATB正在通过内部研发计划和外部合作伙伴关系建立自己的特色产品线，最初的重点是解决免疫学和癌症方面尚未满足的医疗需求。